142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

307271
Prevalence and Trend of Undiagnosed Hypertension (HTN) in the US from 1999 to 2010: An NHANES Study

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014

Maureen Kennedy, DrPH , Department of Epidemiology and Community Health, School of Health Science and Practice, Valhalla, NY
Eda Sweetman, BS , Department of Epidemiology and Community Health, School of Health Science and Practice, Valhalla, NY
Katherine Fellows, BS , Department of Epidemiology and Community Health, School of Health Science and Practice, Valhalla, NY
Jenella Coutts, BS , Department of Epidemiology and Community Health, School of Health Science and Practice, Valhalla, NY
Ethar Mohammed, MD , Department of Epidemiology and Community Health, School of Health Science and Practice, Valhalla, NY
Allison Pool, BS , Department of Epidemiology and Community Health, School of Health Science and Practice, Valhalla, NY
Lisa A Marrero, MD , Department of Epidemiology and Community Health, School of Health Science and Practice, Valhalla, NY
Qiuhu Shi, PhD , Department of Epidemiology and Community Health, School of Health Science and Practice, Valhalla, NY
Prevalence and Trend of Undiagnosed Hypertension (HTN) in the US from 1999 – 2010: An NHANES study.

Background:  Hypertension remains one of the leading causes of coronary heart disease in the US. Early diagnosis and treatment are important for establishing preventive measures that can decrease the financial burden on our healthcare system.

Objectives: Describe the prevalence and trend of undiagnosed HTN cases from 1999 through 2010 and associated risk factors.

Methods: 18,264 participants aged 20 and older who completed continuous NHANES survey from 1999 – 2010, were never told they had HTN and non-pregnant women were included in this analysis. Constructing weights were used for nationwide estimates. Undiagnosed HTN was defined by systolic (≥ 140 mm) or diastolic (≥ 90mm) blood pressure measurements. 

Results:The overall prevalence of undiagnosed HTN was 10.13%. There was a 4.23% decrease from 2000 (12.42%) to 2010 (8.19%). By gender: the males were 13.73% and the females 11.99%; by age: 32.27% in age 60+, 10.82% in age 40-59, and 4.23% in age 20-39; by race: the highest (14.57%) in Non-Hispanic Blacks, follow by Non-Hispanic White (13.39%), Mexican American (12.07%), other race (9.69%); by BMI: 14.94% for ≥ 30, 13.53% for 25-30, and 10.20% for < 25; by the ratio of family income to poverty: 13.25% for the lowest (< 1.3), 13.89% for the middle (1.3-3.5), 11.22% for the highest socioeconomic status.

Conclusion: Ten-year prevalence of undiagnosed HTN decreased by 34% remaining as high as 8.19%. One third of those over sixty years old were found to be hypertensive, yet were never diagnosed.   

 

Learning Areas:

Chronic disease management and prevention
Public health biology
Public health or related education

Learning Objectives:
Evaluate the trend of undiagnosed HTN in the US from 1999 -2010. Analyze specific risk factors for undiagnosed HTN. Identify personal characteristics and biological markers that increase the risk of HTN. Describe high risk populations and population disparity gaps for HTN.

Keyword(s): Chronic Disease Management and Care, Hypertension

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified to be an abstract author because I am an experienced epidemiologist who has performed numerous analyses and provide professional consultations for researchers interested in designing studies to investigate pubic health issues. I am also the Director of the MPH program at NYMC School of Health Science and Practice.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.